Complement activation in patients with neuromyelitis optica.

Complement activation in patients with neuromyelitis optica.

Show other versions (1)

The role of complement has been demonstrated in experimental models of neuromyelitis optica (NMO), however, only few studies have analysed complement components longitudinally in NMO patients. We measured serum or plasma concentrations of anti-C1q antibodies and complement split products C3a and C4a...

Descrición completa

Detalles Bibliográficos
Main Authors:	Nytrova, P, Potlukova, E, Kemlink, D, Woodhall, M, Horakova, D, Waters, P, Havrdova, E, Zivorova, D, Vincent, A, Trendelenburg, M
Formato:	Journal article
Idioma:	English
Publicado:	2014

Títulos similares

Complement activation in patients with neuromyelitis optica
por: Nytrova, P, et al.
Publicado: (2014)

C3a complement split product: possible biomarker of disease activity in patients with neuromyelitis optica
por: Nytrova, P, et al.
Publicado: (2013)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
por: Saadoun, S, et al.
Publicado: (2010)

Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
por: Waters, P, et al.
Publicado: (2016)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
por: Jacob, S, et al.
Publicado: (2008)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
por: Kitley, J, et al.
Publicado: (2012)

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.
por: Woodhall, M, et al.
Publicado: (2013)

Immunological insights into the mechanisms by which RTX is effective in Neuromyelitis Optica spectrum disorders
por: Damato, V, et al.
Publicado: (2019)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
por: Nour, M, et al.
Publicado: (2014)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
por: Kitley, J, et al.
Publicado: (2013)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
por: Absoud, M, et al.
Publicado: (2014)

Neuromyelitis optica relapses: race and rate, immunosuppression and impairment
por: Tackley, G, et al.
Publicado: (2016)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
por: Kitley, J, et al.
Publicado: (2011)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
por: Cavus, F, et al.
Publicado: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
por: Kitley, J, et al.
Publicado: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
por: Kitley, J, et al.
Publicado: (2013)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
por: Min, J, et al.
Publicado: (2013)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
por: Jarius, S, et al.
Publicado: (2008)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
por: Jacob, S, et al.
Publicado: (2007)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
por: Kitley, J, et al.
Publicado: (2013)

Utility of aquaporin-4 antibody assay in patients with neuromyelitis optica spectrum disorders.
por: Kim, S, et al.
Publicado: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Waters, P, et al.
Publicado: (2015)

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica.
por: Jarius, S, et al.
Publicado: (2008)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
por: Mader Simone, et al.
Publicado: (2011-12-01)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
por: Viegas, S, et al.
Publicado: (2009)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
por: Kitley, J, et al.
Publicado: (2012)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
por: Akman-Demir, G, et al.
Publicado: (2011)

Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays.
por: Waters, P, et al.
Publicado: (2008)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
por: Collongues, N, et al.
Publicado: (2013)

Neuromyelitis Optica
por: Goyal V, et al.
Publicado: (2009-10-01)

Neuromyelitis optica
por: Jacob Anu, et al.
Publicado: (2007-01-01)

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain
por: Saadoun, S, et al.
Publicado: (2013)

Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders
por: Katsuichi Miyamoto, et al.
Publicado: (2023-03-01)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
por: Kitley, J, et al.
Publicado: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
por: Kitley, J, et al.
Publicado: (2014)

Neuromyelitis optica IgG causes placental inflammation and fetal death.
por: Saadoun, S, et al.
Publicado: (2013)

Sex bias in multiple sclerosis and neuromyelitis optica spectrum disorders: How it influences clinical course, MRI parameters and prognosis
por: Petra Nytrova, et al.
Publicado: (2022-08-01)

Anti-MOG Antibodies in Japanese Patients with Neuromyelitis Optica Spectrum Disorders
por: Sato, D, et al.
Publicado: (2014)

Rituximab abrogates aquaporin-4-specific germinal center activity in patients with neuromyelitis optica spectrum disorders
por: Damato, V, et al.
Publicado: (2022)

Cell-based assay for anti-AQP4 antibody in Korean patients with neuromyelitis optica
por: Kim, B, et al.
Publicado: (2010)